Liver cancer
CA Cancer J Clin
.
1989 Jul-Aug;39(4):206-18.
doi: 10.3322/canjclin.39.4.206.
Authors
R A Oberfield
1
,
G Steele Jr
,
J L Gollan
,
D Sherman
Affiliation
1
Section of Oncology, Lahey Clinic Medical Center, Burlington, Massachusetts.
PMID:
2547500
DOI:
10.3322/canjclin.39.4.206
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Agents / therapeutic use
Carcinoma, Hepatocellular*
Cohort Studies
Combined Modality Therapy
Hepatectomy
Humans
Liver Neoplasms* / secondary
Radiotherapy Dosage
Risk Factors
Substances
Antineoplastic Agents